Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

FDA approves BECLOMETHASONE DIPROPIONATE from AMNEAL IRELAND LTD

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 3
  • 0 comments

Final approval of ANDA #ANDA #213811 for BECLOMETHASONE DIPROPIONATE. Decision date: 12/16/2025

Comment Full text

FDA updates labeling for TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 5
  • 0 comments

Labeling changes approved for MACLEODS PHARMS LTD. Active ingredient: ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE. Decision date: 12/15/2025

Comment Full text

FDA updates labeling for LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 4
  • 0 comments

Labeling changes approved for ALEMBIC PHARMS LTD. Active ingredient: HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM. Decision date: 12/16/2025

Comment Full text

FDA approves HALOPERIDOL from CREEKWOOD PHARMS

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 5
  • 0 comments

Final approval of ANDA #ANDA #218162 for HALOPERIDOL. Decision date: 12/18/2025

Comment Full text

FDA approves NUFYMCO from FORMYCON AG

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 5
  • 0 comments

Final approval of BLA #BLA #761473 for RANIBIZUMAB-LEYK. Decision date: 12/18/2025

Comment Full text

FDA approves CARIPRAZINE HYDROCHLORIDE from AUROBINDO PHARMA LTD

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 0
  • 0 comments

Final approval of ANDA #ANDA #213982 for CARIPRAZINE HYDROCHLORIDE. Decision date: 12/16/2025

Comment Full text

FDA approves manufacturing change for FLUTICASONE PROPIONATE

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 1
  • 0 comments

Manufacturing process update for AUROBINDO PHARMA LTD. Submission: SUPPL-1. Decision date: 12/16/2025

Comment Full text

FDA updates labeling for XTANDI

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 1
  • 0 comments

Labeling changes approved for ASTELLAS. Active ingredient: ENZALUTAMIDE. Decision date: 12/11/2025

Comment Full text

FDA updates labeling for NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 8
  • 0 comments

Labeling changes approved for SUN PHARM INDS LTD. Active ingredient: NALOXONE HYDROCHLORIDE; PENTAZOCINE HYDROCHLORIDE. Decision date: 12/15/2025

Comment Full text

FDA updates labeling for TRAMADOL HYDROCHLORIDE

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 0
  • 0 comments

Labeling changes approved for TEVA. Active ingredient: TRAMADOL HYDROCHLORIDE. Decision date: 12/11/2025

Comment Full text
  • Previous
  • 32
  • 33
  • 34
  • 35
  • 36
  • Next

Search

News categories

  • Technical Exchange News(10866)
  • Event(2238)
  • SEC News(188879)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124452)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin